Penny Stock Days Over? :)Could this be the end of being a penny stock? This would be another day to remember.
I know that some may want to de-risk, and I get it. But remember:
- Great second line treatment and health profile
- Unmet need
- 2nd line accelerated FDA approval looks good when you look at the history and endpoint data of other drugs
- Huge possibility for 1st line treatment in future on other types of cancers.
- TST has a product that will help millions :)
Stay strong and hold on- we are going higher... much higher!